Skip to content

CXG Roped In by BSGM to Acquire Broker-Dealer Registered with FINRA and SEC, Expanding Public Trading Tokenization of Risk Asset Guarantees

USA, Los Angeles, July 14, 2025 - Chainwire Announcement:

CXG Corporation is hired by BSGM to purchase a broker-dealer registered with FINRA and SEC, aiming...
CXG Corporation is hired by BSGM to purchase a broker-dealer registered with FINRA and SEC, aiming to broaden their operations in tokenizing publicly traded risk-weighted assets.

CXG Roped In by BSGM to Acquire Broker-Dealer Registered with FINRA and SEC, Expanding Public Trading Tokenization of Risk Asset Guarantees

In a significant move, BioSig Technologies, Inc. (NASDAQ: BSGM) has merged with Streamex Exchange Corporation, marking a strategic shift towards the blockchain and commodities market. The merged entity, now wholly owned by BioSig, aims to become one of the first NASDAQ-listed SEC and FINRA compliant issuers of Real-World Asset (RWA) tokens in the U.S.

To oversee this acquisition and ensure seamless integration, BioSig has enlisted the services of Compliance Exchange Group (CXG). CXG, a specialist in building, managing, and supporting Broker-Dealer infrastructure, will lead and manage the acquisition of a FINRA and SEC-registered broker-dealer. This move is expected to provide Streamex with a significant first-mover advantage in the U.S. market for tokenized investment opportunities backed by RWAs, particularly focusing on fully compliant gold-backed tokenized assets.

Streamex is a gold treasury and infrastructure company building on-chain commodity markets. Its mission is to reshape global finance by bringing the approximately $142 trillion global commodities market on chain. The company plans to hold significant quantities of vaulted gold by 2026, denominating its balance sheet in physical gold to support a recurring revenue model.

The acquisition will also provide Streamex with the regulatory framework to issue and trade tokenized assets under federal securities laws. This is a unique milestone in the U.S. RWA tokenization space, as it will enable BioSig to issue and trade tokenized assets for the first time as a NASDAQ-listed company, fully compliant with SEC and FINRA regulations.

Streamex's Solana-based blockchain enables fast, low-cost issuance and trading of gold-backed tokens, making gold investment accessible to all. The company's proprietary on-chain RWA commodity market is designed to leverage this to accelerate adoption and growth in the $22 trillion global gold market within the much larger commodities sector.

The PURE EP Platform, BioSig Technologies' technology, delivers insights for ablation treatments of cardiovascular arrhythmias. While this technology is not directly related to the acquisition and the move towards RWA tokenization, it underscores BioSig's commitment to innovation and its diverse portfolio.

For further and up-to-date details, you can refer to BioSig Technologies’ official press releases posted on their website or financial news platforms such as BusinessWire, Ainvest, and Coin World. These sources provide comprehensive coverage of the acquisition progress, strategic implications, and regulatory compliance status. These announcements offer insight into the acquisition’s impact on BioSig’s position as a pioneering tokenized asset issuer and the expansion of the Streamex RWA commodity platform.

  1. BioSig Technologies aims to become one of the first NASDAQ-listed companies to issue Real-World Asset (RWA) tokens, marking a strategic shift towards blockchain and commodities market.
  2. CXG, a specialist in building, managing, and supporting Broker-Dealer infrastructure, will lead the acquisition of a FINRA and SEC-registered broker-dealer, overseeing this move towards RWA tokenization.
  3. Streamex's gold-backed tokenized assets will now comply with federal securities laws, thanks to the regulatory framework provided by the acquisition.
  4. The low-cost, fast issuance, and trading of gold-backed tokens on Streamex's Solana-based blockchain will make gold investment accessible, accelerating adoption and growth in the $22 trillion global gold market.
  5. Despite the shift towards RWA tokenization, BioSig's PURE EP Platform remains focused on delivering insights for ablation treatments of cardiovascular arrhythmias, showcasing the company's commitment to innovation and diverse portfolio.

Read also:

    Latest